SCHEMBL14133536

SCHEMBL14133536

CCS(=O)(=O)Nc1ccc(C2=NN(C(=O)c3ccco3)C(c3cccc(F)c3)C2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 12/20 1.00
▸ ALDH1A1 P00352 10/20 1.00
▸ KDM4E B2RXH2 8/20 1.00
▸ MAPT P10636 4/20 1.00
▸ HPGD P15428 3/20 0.76
▸ HTT P42858 2/20 0.76
▸ CYP3A4 P08684 1/20 0.76
▸ CYP2C9 P11712 1/20 0.76
▸ CYP2C19 P33261 1/20 0.76
▸ NPSR1 Q6W5P4 1/20 0.76
▸ NPC1 O15118 1/20 0.74
▸ LMNA P02545 2/20 0.69
▸ POLB P06746 3/20 0.67
▸ GAA P10253 4/20 0.61
▸ KMT2A Q03164 5/20 0.53
▸ MEN1 O00255 4/20 0.53
▸ BCL2 P10415 2/20 0.53
▸ BECN1 Q14457 2/20 0.53
▸ GLA P06280 3/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14133806 0.92 PKM (1.00) PKMALDH1A1KDM4EMAPTHPGD
SCHEMBL14133529 0.91 PKM (0.85) PKMALDH1A1KDM4EMAPTHPGD
SCHEMBL14133778 0.90 PKM (0.86) PKMALDH1A1KDM4EMAPTHPGD
SCHEMBL14133385 0.86 PKM (1.00) PKMALDH1A1KDM4EMAPTHPGD
SCHEMBL14133539 0.86 ALDH1A1 (0.75) PKMALDH1A1KDM4EMAPTHPGD
SCHEMBL14133355 0.85 KDM4E (0.74) PKMALDH1A1KDM4EMAPTHPGD
SCHEMBL14133776 0.85 PKM (0.84) PKMALDH1A1KDM4EMAPTHPGD
SCHEMBL14133522 0.84 PKM (0.82) PKMALDH1A1KDM4EMAPTHPGD
SCHEMBL14136253 0.84 PKM (0.72) PKMALDH1A1KDM4EMAPTHPGD
SCHEMBL14133533 0.83 KDM4E (0.71) PKMALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120302609-A1 Pyrazolines for the Modulation of PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-11-29 — — US disclosed
WO-2012160447-A1 3, 5 -DIPHENYL- SUBSTITUTED PYRAZOLINES FOR THE TREATMENT OF CANCER, PROLIFERATIVE, INFLAMMATORY OR AUTOIMMUNE DISEASES DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-11-29 — — WO disclosed
US-20120302609-A1 Pyrazolines for the Modulation of PKM2 DYNAMIX PHARMACEUTICALS LTD. (IL) 2012-11-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120302609-A1 Pyrazolines for the Modulation of PKM2 PDK2, PDK4, PDK3 PKM 5/4885ALDH1A1 2476/4885KDM4E 376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback